News|Articles|April 26, 2024
Pharmatech Insights – Business Considerations for Pharmaceutical Continuous Manufacturing
Author(s)Pharmatech Associates
Continuous Manufacturing in pharmaceuticals can increase process understanding while overcoming disadvantages of batch manufacturing: slow and expensive development and tech transfer, plus inefficiencies, product loss, and human error in commercial manufacturing.
Related Content
Trending on Pharmaceutical Technology
1
Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement
2
Technology Transfer: Success Drivers and Obstacles Explained
3
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
4
Managing Global Trial Supply Risk: Expert Insights
5